US FDA Commissioner Scott Gottlieb has two additional centers of excellence already in mind – immunology and neuroscience – should the model implemented for oncology work as planned.
Both, like the Oncology Center of Excellence that launched at the beginning of 2017, would allow experts in the fields...






